Hsu I-Chow J, Lessard Etienne, Weinberg Vivian, Pouliot Jean
Department of Radiation Oncology, University of California San Francisco, Comprehensive Cancer Center, 1600 Divisadero Street, Suite H1031, San Francisco, CA 94143-1708, USA.
Brachytherapy. 2004;3(3):147-52. doi: 10.1016/j.brachy.2004.05.007.
An inverse planning simulated annealing (IPSA) algorithm for optimization of high-dose-rate (HDR) brachytherapy has been previously described. In this study, IPSA is compared with geometrical optimization (GO) for prostate brachytherapy.
Using CT data collected from 10 patients, treatment plans were prepared using GO and IPSA. The clinical target volume (CTV) and critical organs (CO) including bladder, rectum, and urethra were contoured using Plato Version 14.2.1 (Nucletron Corp., Veenendaal, The Netherlands). Implant catheters were digitized using the CT planning system. All dwell positions outside of the CTV were turned off. Two optimized plans were generated for each implant using GO and IPSA. The same set of dose constraints were used for all inverse planning calculations and no manual adjustment of the dwell weight was used. Two prescription methods were used. Using the first method, coverage was prioritized: the prescription dose was normalized to the isodose volume that covers 98% of the CTV (V100 = 98% of CTV). The dose volume histograms (DVH) of CO were generated for comparison. Using the second method, sparing was prioritized: the prescription dose was normalized such that no urethra volume received 150% of the prescription dose (V150-urethra = 0 cc). The DVH of CTV and CO were generated, and the homogeneity index (HI) and conformal index (COIN) were calculated for comparison and compared using the Wilcoxon matched-pairs test.
Using the coverage-prioritized method, the difference in V80-bladder dose was not statistically significant (p = 0.09; median: IPSA = 0.62 cc, GO = 1.05 cc). The V80-rectum ranged from 0.20-4.8 cc, and 0.05-1.4 cc using GO and IPSA, respectively. IPSA's V80-rectum was significantly lower (p = 0.005; median: IPSA=0.38 cc, GO = 1.31 cc). V150-urethra ranged from 0.02-0.75 cc and 0.0-0.01 cc using GO and IPSA, respectively. The V150-urethra was significantly lower using IPSA (p = 0.005; median: IPSA = 0.00 cc, GO = 0.33 cc). Using the sparing prioritized method, the V100-prostate ranged from 30-97% and 95-100% using GO and IPSA, respectively. This difference was statistically significant (p = 0.008). The HI and COIN were statistically higher using IPSA (p = 0.005).
Anatomy-based inverse optimization using IPSA is superior to dwell-position-based optimization using GO as it: (1) Improves target coverage and conformality while sparing normal structures, (2) Improves dose homogeneity within the target, and (3) Minimizes volume of non-contoured normal tissue irradiated. Routine application of three-dimensional brachytherapy planning and anatomy-based inverse dwell time optimization is recommended.
先前已描述了一种用于优化高剂量率(HDR)近距离放射治疗的逆向计划模拟退火(IPSA)算法。在本研究中,将IPSA与前列腺近距离放射治疗的几何优化(GO)进行比较。
使用从10名患者收集的CT数据,使用GO和IPSA制定治疗计划。使用Plato版本14.2.1(荷兰维嫩代尔的Nucletron公司)勾勒出临床靶区(CTV)和包括膀胱、直肠和尿道在内的关键器官(CO)。使用CT计划系统对植入导管进行数字化处理。关闭CTV外的所有驻留位置。使用GO和IPSA为每个植入物生成两个优化计划。所有逆向计划计算均使用相同的剂量约束集,且未手动调整驻留权重。使用了两种处方方法。使用第一种方法时,优先考虑覆盖范围:将处方剂量归一化为覆盖98% CTV的等剂量体积(V100 = CTV的98%)。生成CO的剂量体积直方图(DVH)进行比较。使用第二种方法时,优先考虑 sparing:将处方剂量归一化,使得没有尿道体积接受150%的处方剂量(V150 - 尿道 = 0 cc)。生成CTV和CO的DVH,并计算均匀性指数(HI)和适形指数(COIN)进行比较,并使用Wilcoxon配对检验进行比较。
使用优先考虑覆盖范围的方法,V80 - 膀胱剂量差异无统计学意义(p = 0.09;中位数:IPSA = 0.62 cc,GO = 1.05 cc)。使用GO时,V80 - 直肠范围为0.20 - 4.8 cc,使用IPSA时为0.05 - 1.4 cc。IPSA的V80 - 直肠显著更低(p = 0.005;中位数:IPSA = 0.38 cc,GO = 1.31 cc)。使用GO时,V150 - 尿道范围为0.02 - 0.75 cc,使用IPSA时为0.0 - 0.01 cc。使用IPSA时,V150 - 尿道显著更低(p = 0.005;中位数:IPSA = 0.00 cc,GO = 0.33 cc)。使用优先考虑 sparing的方法,使用GO时,V100 - 前列腺范围为30 - 97%,使用IPSA时为95 - 100%。这种差异具有统计学意义(p = 0.008)。使用IPSA时,HI和COIN在统计学上更高(p = 0.005)。
使用IPSA的基于解剖的逆向优化优于使用GO的基于驻留位置的优化,因为它:(1)在保护正常结构的同时提高了靶区覆盖和适形性,(2)改善了靶区内的剂量均匀性,(3)使受照射的未勾勒正常组织体积最小化。建议常规应用三维近距离放射治疗计划和基于解剖的逆向驻留时间优化。